Drugs / Moxifloxacin/dexamethasone phosphate
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00579020 | Dec 2007 → Feb 2009 | keratitis | Alcon Research | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Moxifloxacin/dexamethasone phosphate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00579020 ↗ |
| Route | Topical | “Moxifloxacin/dexamethasone phosphate ophthalmic solution, one drop in cul-de-sac and 4 drops on closed lids of study eye(s), four times a day, for seven days” NCT00579020 ↗ |